Form 8-K SEQUENOM INC For: Jan 20

�

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

�

�

FORM 8-K

�

�

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): January�20, 2015

�

�

SEQUENOM, INC.

(Exact Name of Registrant as Specified in Charter)

�

�

�

DELAWARE	�	000-29101	�	77-0365889
(State or Other Jurisdiction of Incorporation)	�	(Commission File Number)	�	(I.R.S. Employer Identification No.)

3595 JOHN HOPKINS COURT

SAN DIEGO, CALIFORNIA 92121

(Address of Principal Executive Offices)

(858) 202-9000

(Registrant�s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

�

�

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

�

�	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

�

�	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

�

�	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

�

�	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

---

Item�5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On January�20, 2015, John A. Fazio, who has served as a member of our Board of Directors since 2007, notified us that he has elected not to stand for re-election to our Board of Directors at our next annual meeting of shareholders.�Mr. Fazio�s decision not to stand for re-election to our Board of Directors does not involve any disagreement with us, our management or our Board of Directors.

�

2.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

�

	�		�	SEQUENOM, INC.
Date: January�23, 2015	�		�	By:	�	/s/ Jeffrey D. Linton
	�		�		�	Jeffrey D. Linton
	�		�		�	Senior Vice President, General Counsel

�

3.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio
• Paramount jumps on report of Sony Pictures, Apollo discussing joint buyout bid
• Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024